Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Clinical trial NCT05419427 · UNKNOWN

Trial details

NCT number: NCT05419427
Sponsor: Lambda Therapeutic Research Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2021-11-11
Primary completion: 2024-09-11
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.